The Monoclonal Antibodies Market has emerged as one of the most transformative sectors within the global biopharmaceutical ...
The OpenFold Consortium today announced a major OpenFold3 update and the public release of training datasets and full-stack tooling for reproducible biomolecular AI. OpenFold3 is an open-source deep ...
Explore the latest developments showcased at World ADC, highlighting smarter payloads and precise targeting in drug discovery.
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
The Draft Academy Expands into Functional Health Services, Utilizing Advanced RPA Protocols to Support High-Performance ...
Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsJennie WillsonJacqueline Shea - CEO, President ...
Scientists at The University of Texas at Austin have pulled off their clearest look yet at the Andes hantavirus, mapping the virus’s surface entry complex at near-atomic detail. That intricate ...
Roberto Mina, MD, details how in the MajesTEC-9 trial, teclistamab monotherapy boosted PFS and OS in relapsed/refractory multiple myeloma, challenging standardized care.
Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...
Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate DevelopmentREHOVOT, Israel, March 13, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results